Corporate : Registered Office and Plant, Genome Valley Shameerpet, Hyderabad – 500 078 Telangana INDIA
Ph: +91 40 2778 4084
Ph: +91 40 2348 0567
Mob: +91 99480 80567
Fax: +91 40 2348 0560
Website: www.bharatbiotech.com
International Business
For International Business related queries, please write to us at: Email: exports02@bharatbiotech.com
Human Resources
For Careers at Bharat Biotech, please write to us at: E-mail: careers@bharatbiotech.com
Ph: +91 40 2778 4084
Tel: +91 40 2348 0567
Media
For Media related queries, contact: E-mail: media@bharatbiotech.com
Feedback
For Feedback, please write to us at: E-mail: feedback@bharatbiotech.com
Bharat Biotech started operations in 1996—the year Dr. Krishna M. Ella and Mrs. Suchitra Ella returned from the US to set up a company dedicated to creating innovative vaccines and bio-therapeutics. Dr. Ella was returning from a research and teaching stint in the US and he wanted the new company to be an intellectual capital powerhouse. In the years that followed, he assembled a team of bright scientists and led the creation of path-breaking vaccines.
Today, Bharat Biotech has over 160 patents. As a leading biotechnology company, we seamlessly straddle the worlds of product research and manufacturing to create effective vaccines and therapeutics for patients around the world. We own 160 global patents and our products help people in over 65 countries live to their fullest potential. Our manufacturing facilities are approved by USFDA, KFDA and WHO. We are committed to provide affordable and innovative vaccines for healthier lives.
Typbar TCV® is the world’s first clinically proven conjugate Typhoid vaccine and received WHO-Prequalification in January 2018.
ROTAVAC® is India’s first and largest efficacy clinical trial on vaccines and "Rotavac® received WHO-Prequalification in January 2018.
Comments
Post a Comment